Avalo Therapeutics, Inc. - 8-K Filing
Avalo Therapeutics enters $200 million at-the-market equity offering with Jefferies and terminates prior sales agreement with TD Cowen. (Items: 1.01 Entry into a Material Definitive Agreement, 1.02 Termination of a Material Definitive Agreement, 9.01 Exhibits (d) Exhibits Exhibit No)
Tickers: $AVTX